Compound details
Northalifoline
| Compound ID | CDAMM01993 |
|---|---|
| Common name | Northalifoline | IUPAC name | 7-hydroxy-6-methoxy-3,4-dihydro-2H-isoquinolin-1-one |
| Molecular formula | C10H11NO3 |
| Retention time | 10.77 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 194.078 | Theoretical mz | 194.081 |
| Error | 14.82 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 7.2246 |
| Inchi key | HSLDNQNDHKZKNZ-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C1NCCC2=CC(OC)=C(O)C=C12 |
| Superclass | Organoheterocyclic compounds |
| Class | Isoquinolines and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P41595 | HTR2B | Serotonin 2b (5-HT2b) receptor | T31204 | SEA |
| P49137 | MAPKAPK2 | MAP kinase-activated protein kinase 2 | T21307 | SEA |
| P21728 | DRD1 | Dopamine D1 receptor | T22118 | SEA |
| O14757 | CHEK1 | Serine/threonine-protein kinase Chk1 | T62449 | SEA |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| O00311 | CDC7 | CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase) | T81358 | SEA |
| P78368 | CSNK1G2 | Casein kinase I gamma 2 | T82773 | SEA |
| P10636 | MAPT | Microtubule-associated protein tau | T45593 | SEA |
| Q96KB5 | PBK | PDZ-binding kinase | T98642 | SEA |
| P51511 | MMP15 | Matrix metalloproteinase 15 | T81658 | SEA |
| Q16236 | NFE2L2 | Nuclear factor erythroid 2-related factor 2 | T88505 | SEA |
| Q9UQM7 | CAMK2A | CaM kinase II alpha | T18299 | SEA |
| Q96PF2 | TSSK2 | Testis-specific serine/threonine-protein kinase 2 | T04413 | SEA |
| O43781 | DYRK3 | Dual-specificity tyrosine-phosphorylation regulated kinase 3 | T97149 | SEA |
| Q9UEE5 | STK17A | Serine/threonine-protein kinase 17A | T91323 | SEA |
| P01100 | FOS | Proto-oncogene c-Fos | T28025 | SEA |
| Q96RG2 | PASK | PAS domain-containing serine/threonine-protein kinase | T37371 | SEA |
| Q9NXA8 | SIRT5 | NAD-dependent deacetylase sirtuin-5 | T91940 | SEA |
| Q9NR20 | DYRK4 | Dual-specificity tyrosine-phosphorylation regulated kinase 4 | T20542 | SEA |
| Q8TDC3 | BRSK1 | BR serine/threonine kinase 1 | T20053 | SEA |
| Q9Y6M4 | CSNK1G3 | Casein kinase I gamma-3 | T29728 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T31204 | DI0040 | Attention deficit hyperactivity disorder | [ICD-11: 6A05] | P41595 | HTR2B |
| T31204 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P41595 | HTR2B |
| T31204 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P41595 | HTR2B |
| T31204 | DI0354 | Psychotic disorder | [ICD-11: 6A20-6A25] | P41595 | HTR2B |
| T21307 | DI0011 | Acute laryngitis/tracheitis | [ICD-11: CA05] | P49137 | MAPKAPK2 |
| T21307 | DI0181 | Hidradenitis suppurativa | [ICD-11: ED92] | P49137 | MAPKAPK2 |
| T21307 | DI0269 | Monogenic autoinflammatory syndrome | [ICD-11: 4A60] | P49137 | MAPKAPK2 |
| T21307 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P49137 | MAPKAPK2 |
| T21307 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P49137 | MAPKAPK2 |
| T21307 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P49137 | MAPKAPK2 |
| T21307 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P49137 | MAPKAPK2 |
| T22118 | DI0003 | Abortion | [ICD-11: JA00] | P21728 | DRD1 |
| T22118 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P21728 | DRD1 |
| T22118 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P21728 | DRD1 |
| T22118 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21728 | DRD1 |
| T62449 | DI0027 | Anal cancer | [ICD-11: 2C00] | O14757 | CHEK1 |
| T62449 | DI0172 | Head and neck cancer | [ICD-11: 2D42] | O14757 | CHEK1 |
| T62449 | DI0183 | Hodgkin lymphoma | [ICD-11: 2B30] | O14757 | CHEK1 |
| T62449 | DI0238 | Lung cancer | [ICD-11: 2C25] | O14757 | CHEK1 |
| T62449 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O14757 | CHEK1 |
| T62449 | DI0321 | Ovarian cancer | [ICD-11: 2C73] | O14757 | CHEK1 |
| T62449 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | O14757 | CHEK1 |
| T62449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O14757 | CHEK1 |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T81358 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00311 | CDC7 |
| T81358 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O00311 | CDC7 |
| T45593 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10636 | MAPT |
| T45593 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10636 | MAPT |
| T45593 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P10636 | MAPT |
| T98642 | DI0291 | Nasopharyngeal cancer | [ICD-11: 2B6B] | Q96KB5 | PBK |
| T88505 | DI0038 | Ataxic disorder | [ICD-11: 8A03] | Q16236 | NFE2L2 |
| T18299 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UQM7 | CAMK2A |